267 results
8-K
EX-2.2
XOMA
XOMA Corp
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:27am
Register to the successor Rights Agent. The Rights Agent shall be entitled to reimbursement by Parent for costs and expenses related to such transition
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
effects and efficacy, (ix) obtain coverage and adequate product reimbursement from third-party payors, including government payors, (x) achieve market … acknowledge and agree that in no event shall Kinnate be required to pay the Termination Fee or the Expense Reimbursement Payment (as defined below) on more than
SC TO-T
EX-99
uztlys
4 Mar 24
Third party tender offer statement
5:24pm
8-K
EX-2.1
pltmh5d3lra
16 Feb 24
XOMA Enters into Agreement to Acquire Kinnate Biopharma
9:08am
8-K
qzjeunv 9a5hlke1
22 Jun 23
Entry into a Material Definitive Agreement
7:45am